Funding has been awarded for the first seven schemes out of 21 lined up for Liverpool City Region’s £160m life sciences investment zone.
The Liverpool City Region Combined Authority has approved a combined £26.5m investment towards those seven projects, which have a total cost of £83m.
The projects include new labs for the Liverpool School of Tropical Medicine-led Infection Innovation Consortium, expansion of Sci-Tech Daresbury, upgrade of TriRx facilities, development of the Microbiome and Infectious Disease Innovation Hub led by the University of Liverpool in partnership with the Centre for Process Innovation, and three life sciences programmes.
Liam Robinson, leader of Liverpool City Council, said: “The health and life sciences sector is genuinely a real strength of our city region.
“We’ve been able to develop this innovation zone that will allow us to unlock a number of strategic science locations, continue to attract new businesses and develop those businesses that are in our city region with the potential of this programme to create 8,000 jobs and unlock up to £800m of public and private sector investments into this sector and into the location.
“This is a really exciting opportunity for our city region that we want to take forward as one of our economic strengths well into the future and I completely endorse the recommendations of the report.”
Final funding approvals are expected to follow in the coming months after further scrutiny.
Image © Sci-Tech Daresbury
Send feedback to Evelina Grecenko
Follow Estates Gazette
